Pharma News New haematology reimbursement in Belgium: axicabtagene ciloleucel (Yescarta®) for ... Read more
Pharma News FDA grants accelerated approval to elranatamab for the treatment of R/R multiple myeloma Read more
Pharma News Marstacimab reduces the annualised bleeding rate in patients with severe haemophilia A or B Read more
Pharma News FDA approves epcoritamab for the treatment of R/R diffuse large B-cell lymphoma Read more
Pharma News Vyxeos liposomal now reimbursed in Belgium for patients with untreated high-risk AML Read more
Pharma News Pirtobrutinib gets FDA approval for relapsed or refractory mantle cell lymphoma Read more
Pharma News FDA approves pirtobrutinib for the treatment of advanced relapsed/refractory mantle cell lymph... Read more
Top
